« Previous Next » Reproductive Health Matters
Volume 13, Issue 26 , Pages 65-74 , November 2005

Availability of Medical Abortion Pills and the Role of Chemists: A Study from Bihar and Jharkhand, India

References

In: Mittal S editors. Consortium on National Consensus for Medical Abortion in India: Proceedings and Recommendations. New Delhi: All India Institute of Medical Sciences; 2004;
All India Institute of Medical Sciences. Use of RU 486 with Misoprostol for Early Abortion in India. Guidelines for medical officers. New Delhi: AIIMS; 2004;
Banerjee A, Tewari S. Clinical cum socio behavioral evaluative study of women seeking termination of early pregnancy (up to 56 days LMP). New Delhi: Parivar Seva Sanstha; 2004;
Coyaji K, Elul B, Krishna U, et al. Mifepristone abortion outside the urban research hospital setting in India. Lancet. 2001;357:120–121
Coyaji K, Elul B, Krishna U, et al. Mifepristone–misoprostol abortion: a trial in rural and urban Maharashtra, India. Contraception. 2002;66(1):33–40
Winikoff B, Sivin I, Coyaji KJ, et al. The acceptability of medical abortion in China, Cuba and India. International Family Planning Perspectives. 1997;23(2):73–78
- CrossRef
Ganatra B, Manning V, Pallipamulla S. Medical abortion in Bihar and Jharkhand: A study of service providers, chemists, women and men. New Delhi: Ipas, 2005.
Khan ME, Barge S, Kumar N, et al. Abortion in India: current situation and future challenges. In: Pachauri S editors. Implementing a Reproductive Health Agenda in India: The Beginning. New Delhi: Population Council; 1999;p. 507–529
Indian Institute for Population Sciences. Report of the Facility Survey under the Reproductive and Child Health (RCH) Project. Mumbai: IIPS; 2001;
Tamang A, Tamang J. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives. Reproductive Health Matters. 2005;13(26):110–119